- Home
- ARVN vs EVTL Comparison
ARVN vs EVTL Comparison
Compare ARVN & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- EVTL
- Stock Information
- Founded
- ARVN 2015
- EVTL 2016
- Country
- ARVN United States
- EVTL United Kingdom
- Employees
- ARVN 430
- EVTL N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- EVTL Aerospace
- Sector
- ARVN Health Care
- EVTL Industrials
- Exchange
- ARVN Nasdaq
- EVTL Nasdaq
- Market Cap
- ARVN 676.2M
- EVTL 542.9M
- IPO Year
- ARVN 2018
- EVTL N/A
- Fundamental
- Price
- ARVN $9.45
- EVTL $4.72
- Analyst Decision
- ARVN Buy
- EVTL Strong Buy
- Analyst Count
- ARVN 23
- EVTL 8
- Target Price
- ARVN $17.61
- EVTL $11.43
- AVG Volume (30 Days)
- ARVN 2.6M
- EVTL 1.9M
- Earning Date
- ARVN 11-04-2025
- EVTL 08-05-2025
- Dividend Yield
- ARVN N/A
- EVTL N/A
- EPS Growth
- ARVN N/A
- EVTL N/A
- EPS
- ARVN N/A
- EVTL N/A
- Revenue
- ARVN $372,800,000.00
- EVTL N/A
- Revenue This Year
- ARVN $1.01
- EVTL N/A
- Revenue Next Year
- ARVN N/A
- EVTL N/A
- P/E Ratio
- ARVN N/A
- EVTL N/A
- Revenue Growth
- ARVN 299.57
- EVTL N/A
- 52 Week Low
- ARVN $5.90
- EVTL $2.76
- 52 Week High
- ARVN $29.61
- EVTL $15.99
- Technical
- Relative Strength Index (RSI)
- ARVN 57.54
- EVTL 39.58
- Support Level
- ARVN $9.01
- EVTL $4.52
- Resistance Level
- ARVN $9.55
- EVTL $4.90
- Average True Range (ATR)
- ARVN 0.49
- EVTL 0.35
- MACD
- ARVN -0.10
- EVTL -0.09
- Stochastic Oscillator
- ARVN 44.37
- EVTL 13.25
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.